Jayant Dey
Endocrinology, Diabetes & Metabolism · Tupelo, MSNPI 1740251941
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in MS, where the typical reported total is $4,678.
Across 96 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$193
- Sanofi-aventis U.S. LLC$183
- Novo Nordisk$179
- Amgen$116
- Shire North American Group Inc$113
- Merck$85
- plus $613 from 16 others
What the payments were for
- Food & beverage$1,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $193 |
| Sanofi-aventis U.S. LLC | 11 | $183 |
| Novo Nordisk | 14 | $179 |
| Amgen | 7 | $116 |
| Shire North American Group Inc | 3 | $113 |
| Merck | 6 | $85 |
| Corcept Therapeutics | 4 | $84 |
| Insulet Corporation | 3 | $57 |
| Ultragenyx Pharmaceutical Inc. | 3 | $54 |
| Medtronic | 3 | $51 |
| Dexcom, Inc. | 3 | $45 |
| Amarin Pharma, Inc. | 2 | $44 |
| Eisai Inc. | 3 | $43 |
| AstraZeneca | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 3 | $38 |
| Johnson & Johnson | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Boehringer Ingelheim | 2 | $26 |
| Vivus LLC | 2 | $20 |
| Mannkind Corporation | 1 | $18 |
| Pfizer | 1 | $18 |
| AbbVie | 1 | $14 |
How this compares
$1,482 in reported general payments places this provider in the 15th percentile of 48 endocrinology, diabetes & metabolism providers in Mississippi.
See all endocrinology, diabetes & metabolism providers in Mississippi →
Other endocrinology, diabetes & metabolism in Tupelo
- Christy OswaltTupelo$27K
- Leonil GanlimTupelo$19K
- Mark ShepherdTupelo$17K
- Eric DyessJackson$885K
- Mark BorcheltGulfport$722K
- Honey EastJackson$721K
- Ben SealeJackson$623K
- Jeremy TaylorMadison$271K
- Amanda SchieferJackson$204K
- Delali BlavoSouthaven$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.